Proton MR Spectroscopy to diagnose Multiple Sclerosis at early stages

Published On 2022-01-29 10:46 GMT   |   Update On 2022-01-29 10:46 GMT
Advertisement

With growing technology medicine has also grown to greater heights, with newer advancements in diagnosis and treatment. MR spectroscopy a new advancement in radiology compares the chemical composition of normal brain tissue.

The journal Radiology suggests that MR spectroscopic imaging at 7.0 T can identify changes in the brains of patients with multiple sclerosis (MS) that were not visible at T1- or T2-weighted MRI. Further, metabolic abnormalities in the normal-appearing white matter and cortical gray matter were found to be related to disability.

Advertisement

Previous studies have shown that MR spectroscopic imaging (MRSI) allows in vivo assessment of brain metabolism. Also, it is of special interest in MS, where morphologic MRI cannot depict major parts of disease activity. Wolfgang Bogner, and the team therefore, aimed to evaluate the ability of 7.0-T MRSI to depict and visualize pathologic alterations in the normal-appearing white matter (NAWM) and cortical gray matter (CGM) in patients with MS and to investigate their relation to disability.

For more information check out the full story on the link below:

7T proton MR spectroscopic imaging can identify brain changes in multiple sclerosis: Study 

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News